Reviewed Mar 2026 | PubMed sources
Active Market
France is selected. The evidence comparison is still valid, but provider availability, legal positioning, and cost assumptions may still be staged for later rollout.

TB-500 vs LL-37: Head-to-Head Comparison

TB-500 and LL-37 both contribute to wound healing but through entirely different pathways. TB-500 promotes cell migration and tissue remodeling via actin regulation, while LL-37 fights infection at wound sites and recruits immune cells. They address complementary aspects of the healing process.

Side-by-Side Comparison

DimensionTB-500LL-37
Evidence LevelAnimal studies, limited human dataEndogenous human peptide, well-characterized biology
FDA StatusNot approvedNot approved as therapeutic
MechanismActin sequestration, cell migration, angiogenesisAntimicrobial membrane disruption, chemotaxis, immune modulation
Primary UseSoft tissue repair, muscle recoveryInfection prevention, biofilm disruption, immune support
Wound Healing RoleTissue remodeling and cell migration phaseInfection control and inflammatory phase
Side EffectsHead rush, temporary lethargyPotential cytotoxicity at high doses
Evidence Level
TB-500
Animal studies, limited human data
LL-37
Endogenous human peptide, well-characterized biology
FDA Status
TB-500
Not approved
LL-37
Not approved as therapeutic
Mechanism
TB-500
Actin sequestration, cell migration, angiogenesis
LL-37
Antimicrobial membrane disruption, chemotaxis, immune modulation
Primary Use
TB-500
Soft tissue repair, muscle recovery
LL-37
Infection prevention, biofilm disruption, immune support
Wound Healing Role
TB-500
Tissue remodeling and cell migration phase
LL-37
Infection control and inflammatory phase
Side Effects
TB-500
Head rush, temporary lethargy
LL-37
Potential cytotoxicity at high doses

Peptide Overviews

TB-500 (Thymosin Beta-4)

CPreclinical

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. It plays a role in cell migration, blood vessel formation, and tissue repair.

Healing & RecoveryNot Approved
View full TB-500 (Thymosin Beta-4) profile →

LL-37

CPreclinical

LL-37 (also written as ll37 or ll-37) is the only cathelicidin antimicrobial peptide found in humans. It plays a crucial role in innate immune defense, wound healing, and inflammation modulation.

Immune SupportNot Approved
View full LL-37 profile →

Supplies for Recovery Protocols

Recovery tools and supplements relevant to this comparison.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

TB-500 vs LL-37: FAQ